hydroxychloroquine has been researched along with Xerophthalmia in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Xerophthalmia: Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.
Excerpt | Relevance | Reference |
---|---|---|
"Although renal tubular acidosis (RTA), secondary to autoimmune interstitial nephritis, develops in a large proportion of patients with Sjögren's syndrome (SS), most of the subjects are asymptomatic." | 1.33 | A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature. ( Celik, Y; Gerenli, M; Pamuk, ON; Soy, M, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rihl, M | 1 |
Ulbricht, K | 1 |
Schmidt, RE | 1 |
Witte, T | 1 |
Soy, M | 1 |
Pamuk, ON | 1 |
Gerenli, M | 1 |
Celik, Y | 1 |
de Winter, S | 1 |
van Buchem, MA | 1 |
Vermeer, MH | 1 |
3 other studies available for hydroxychloroquine and Xerophthalmia
Article | Year |
---|---|
Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Autoantibodies; Carrier Proteins; Female; Huma | 2009 |
A primary Sjögren's syndrome patient with distal renal tubular acidosis, who presented with symptoms of hypokalemic periodic paralysis: Report of a case study and review of the literature.
Topics: Acidosis, Renal Tubular; Adult; Antirheumatic Agents; Diagnosis, Differential; Drug Therapy, Combina | 2005 |
Annular erythema of Sjögren's syndrome.
Topics: Adult; Dermatologic Agents; Erythema; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Syste | 2006 |